Verapamil, a calcium channel blocker, is used as the racemate. Recently, racemic verapamil has been shown to increase the cytotoxicity of vinca alkaloid and anthracycline derivatives in several resistant tumour cell lines. With respect to its cardiovascular activity S-verapamil is an order of magnit
Verapamil preferentially potentiates in-vitro cytotoxicity of vincristine on malignant lymphoid cells
β Scribed by Dr Imtiaz A. Malik; Nicolas V. Costea
- Publisher
- John Wiley and Sons
- Year
- 1992
- Tongue
- English
- Weight
- 484 KB
- Volume
- 10
- Category
- Article
- ISSN
- 0278-0232
No coin nor oath required. For personal study only.
β¦ Synopsis
Verapamil has been shown to overcome acquired drug resistance to vincristine in P388 leukemia both in vitro and in vivo. To study the selectivity of this action, the effect of addition of verapamil on the cytotoxicity of vincristine was studied using lymphocytes from eight patients with chronic lymphocytic leukemia (CLL), lymphoblasts from a T-acute lymphoblastic leukemia (T-ALL) cell line (GM 3639), and peripheral blood lymphocytes (PBL) from eight normal healthy volunteers. Using the differential staining cytotoxicity (DiSC) assay, we demonstrated that verapamil at 1 p~ concentration potentiated the in-vitro cytotoxicity of vincristine on CLL and GM 3639 cells in concentrations of 0-04-0.25 pg/l. There was however, no enhancement of cytotoxicity noted against the control PBL. The data demonstrate that verapamil preferentially enhances the in-virro cytotoxicity of vincristine on CLL and GM 3639 cells but no enhancement of cytotoxicity is seen against PBL.
π SIMILAR VOLUMES
## Abstract One or 4 weeks after grafting of a syngeneic sarcoma (T~2~) to C57BL/6 mice, lymphβnode cells (LNC) are cytotoxic __in vitro__ for the cells of this tumour. But after 2 weeks LNC are not cytotoxic or show a nonβsignificant activity. These secondβweek LNC, added to cytotoxic lymphocytes
A novel fluorometric microculture cytotoxicity assay (FMCA), based on measurements of fluorescein diacetate (FDA) hydrolysis and DNA staining by Hoechst 33342, was used for drug sensitivity testing and detection of resistance reversal in acute lymphoblastic leukemia (ALL) cell lines. The 72-hr assay